Do Patients with Luminal A Breast Cancer Profit from Adjuvant Systemic Therapy? A Retrospective Multicenter Study

• Joachim Diessner ,

  Contributed equally to this work with: Joachim Diessner, Manfred Wischnewsky

  * E-mail: Diessner-bw@t-online.de

  Affiliation Department for Obstetrics and Gynecology, University of Würzburg Medical School, Würzburg, Germany

  ⨯
• Manfred Wischnewsky ,

  Contributed equally to this work with: Joachim Diessner, Manfred Wischnewsky

  Affiliation Faculty of Mathematics and Computer Science, University of Bremen Bremen, Germany

  ⨯
• Maria Blettner,

  Affiliation Institut für Medizinische Biometrie, Epidemiologie und Informatik (IMBEI), University of Mainz, Mainz, Germany

  ⨯
• Sebastian Häusler,

  Affiliation Department for Obstetrics and Gynecology, University of Würzburg Medical School, Würzburg, Germany

  ⨯
• Wolfgang Janni,

  Affiliation Department for Obstetrics and Gynecology, University of Ulm Medical School Ulm, Germany

  ⨯
• Rolf Kreienberg,

  Affiliation Department for Obstetrics and Gynecology, University of Ulm Medical School Ulm, Germany

  ⨯
• Roland Stein,

  Affiliation Department for Obstetrics and Gynecology, University of Würzburg Medical School, Würzburg, Germany

  ⨯
• Tanja Stüber,

  Affiliation Department for Obstetrics and Gynecology, University of Würzburg Medical School, Würzburg, Germany

  ⨯
• Lukas Schwentner,

  Affiliation Department for Obstetrics and Gynecology, University of Ulm Medical School Ulm, Germany

  ⨯
• Catharina Bartmann,

  Affiliation Department for Obstetrics and Gynecology, University of Würzburg Medical School, Würzburg, Germany

  ⨯
• Achim Wöckel

  Affiliation Department for Obstetrics and Gynecology, University of Würzburg Medical School, Würzburg, Germany

  ⨯